Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000762397 | SCV000892710 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | TNXB: BS2 |
Gene |
RCV000762397 | SCV001831099 | benign | not provided | 2018-12-11 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002279523 | SCV002566261 | likely benign | Ehlers-Danlos syndrome | 2022-07-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002332543 | SCV002631322 | likely benign | Cardiovascular phenotype | 2020-12-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003938149 | SCV004754795 | benign | TNXB-related disorder | 2021-05-25 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |